The World Market for Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings: A 2009 Global Trade Perspective
ICON Group International, September 2008, Pages: 203
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings? What is the dollar value of these imports? How much do the imports of medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings, for each individual country. Chapter 4 does the same, but for imports of medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings (i.e. their market shares are close or equal to zero percent). "Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings" is 54213 .
1 METHODOLOGY 12
1.1 Our Approach 12
2 THE WORLD MARKET 16
2.1 Exports 16
2.1.1 The World Market: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Export Supplies in 2009 16
2.2 Imports 19
2.2.1 The World Market: Imported Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings in 2009 19
3 EXPORTS 23
3.1 Africa: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings 23
3.1.1 Executive Summary 23
3.1.2 Benin 25
3.1.3 Egypt 25
3.1.4 Kenya 26
3.1.5 Mauritius 26
3.1.6 Morocco 26
3.1.7 Sierra Leone 27
3.1.8 South Africa 27
3.1.9 the Gambia 27
3.1.10 Tunisia 28
3.1.11 Zambia 28
3.1.12 Zimbabwe 28
3.2 Asia: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings 29
3.2.1 Executive Summary 29
3.2.2 Bangladesh 32
3.2.3 China 33
3.2.4 Hong Kong 34
3.2.5 India 35
3.2.6 Indonesia 36
3.2.7 Japan 36
3.2.8 Malaysia 37
3.2.9 North Korea 37
3.2.10 Philippines 37
3.2.11 Singapore 38
3.2.12 South Korea 38
3.2.13 Taiwan 39
3.2.14 Thailand 39
3.3 Europe: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings 39
3.3.1 Executive Summary 39
3.3.2 Austria 44
3.3.3 Belarus 45
3.3.4 Belgium 46
3.3.5 Bosnia and Herzegovina 47
3.3.6 Bulgaria 47
3.3.7 Croatia 47
3.3.8 Cyprus 48
3.3.9 Czech Republic 49
3.3.10 Denmark 49
3.3.11 Estonia 50
3.3.12 Finland 50
3.3.13 France 51
3.3.14 Georgia 52
3.3.15 Germany 53
3.3.16 Greece 54
3.3.17 Hungary 54
3.3.18 Iceland 55
3.3.19 Ireland 56
3.3.20 Italy 57
3.3.21 Kazakhstan 58
3.3.22 Latvia 58
3.3.23 Lithuania 58
3.3.24 Luxembourg 59
3.3.25 Macedonia 59
3.3.26 Malta 59
3.3.27 Moldova 60
3.3.28 Norway 60
3.3.29 Poland 61
3.3.30 Portugal 62
3.3.31 Romania 62
3.3.32 Russia 63
3.3.33 Slovakia 63
3.3.34 Slovenia 64
3.3.35 Spain 65
3.3.36 Sweden 66
3.3.37 Switzerland 67
3.3.38 the Netherlands 68
3.3.39 the United Kingdom 69
3.3.40 Ukraine 70
3.4 Latin America: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail 70
3.4.1 Executive Summary 70
3.4.2 Argentina 73
3.4.3 Bolivia 74
3.4.4 Brazil 74
3.4.5 Chile 75
3.4.6 Colombia 75
3.4.7 Costa Rica 76
3.4.8 Ecuador 76
3.4.9 El Salvador 76
3.4.10 Guatemala 77
3.4.11 Mexico 77
3.4.12 Panama 78
3.4.13 Paraguay 78
3.4.14 Peru 78
3.4.15 Uruguay 79
3.4.16 Venezuela 79
3.5 North America & the Caribbean: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage 79
3.5.1 Executive Summary 79
3.5.2 Aruba 82
3.5.3 Barbados 82
3.5.4 Canada 83
3.5.5 Cuba 83
3.5.6 Dominican Republic 84
3.5.7 the Bahamas 84
3.5.8 the Netherlands Antilles 84
3.5.9 the United States 85
3.6 Oceana: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings 86
3.6.1 Executive Summary 86
3.6.2 Australia 88
3.6.3 New Zealand 88
3.7 the Middle East: Export Supplies of Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail 89
3.7.1 Executive Summary 89
3.7.2 Iran 91
3.7.3 Israel 91
3.7.4 Jordan 92
3.7.5 Kyrgyzstan 92
3.7.6 Pakistan 92
3.7.7 Saudi Arabia 93
3.7.8 Syrian Arab Republic 93
3.7.9 the United Arab Emirates 94
3.7.10 Turkey 95
4 IMPORTS 96
4.1 Africa: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports in 2009 96
4.1.1 Executive Summary 96
4.1.2 Algeria 100
4.1.3 Botswana 101
4.1.4 Cameroon 101
4.1.5 Cape Verde 102
4.1.6 Cote dIvoire 102
4.1.7 Egypt 103
4.1.8 Ethiopia 104
4.1.9 Gabon 104
4.1.10 Ghana 105
4.1.11 Madagascar 105
4.1.12 Malawi 106
4.1.13 Mauritania 106
4.1.14 Mauritius 106
4.1.15 Morocco 107
4.1.16 Mozambique 108
4.1.17 Namibia 108
4.1.18 Senegal 109
4.1.19 South Africa 109
4.1.20 Sudan 110
4.1.21 Tanzania 111
4.1.22 the Gambia 111
4.1.23 Uganda 112
4.2 Asia: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports in 2009 112
4.2.1 Executive Summary 112
4.2.2 Brunei 115
4.2.3 China 116
4.2.4 Hong Kong 117
4.2.5 India 118
4.2.6 Indonesia 118
4.2.7 Japan 119
4.2.8 Macau 119
4.2.9 Malaysia 120
4.2.10 Mongolia 120
4.2.11 Philippines 121
4.2.12 Singapore 122
4.2.13 South Korea 122
4.2.14 Taiwan 123
4.2.15 Thailand 123
4.3 Europe: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports in 2009 123
4.3.1 Executive Summary 124
4.3.2 Albania 128
4.3.3 Austria 129
4.3.4 Belarus 130
4.3.5 Belgium 131
4.3.6 Bosnia and Herzegovina 132
4.3.7 Bulgaria 132
4.3.8 Croatia 133
4.3.9 Cyprus 133
4.3.10 Czech Republic 134
4.3.11 Denmark 135
4.3.12 Estonia 136
4.3.13 Finland 137
4.3.14 France 138
4.3.15 Georgia 139
4.3.16 Germany 140
4.3.17 Greece 141
4.3.18 Hungary 142
4.3.19 Iceland 143
4.3.20 Ireland 144
4.3.21 Italy 145
4.3.22 Kazakhstan 146
4.3.23 Latvia 147
4.3.24 Lithuania 147
4.3.25 Luxembourg 148
4.3.26 Macedonia 148
4.3.27 Malta 149
4.3.28 Moldova 149
4.3.29 Norway 150
4.3.30 Poland 151
4.3.31 Portugal 152
4.3.32 Romania 153
4.3.33 Russia 154
4.3.34 Slovakia 155
4.3.35 Slovenia 156
4.3.36 Spain 157
4.3.37 Sweden 158
4.3.38 Switzerland 158
4.3.39 the Netherlands 159
4.3.40 the United Kingdom 160
4.3.41 Ukraine 161
4.4 Latin America: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports in 161
4.4.1 Executive Summary 161
4.4.2 Argentina 164
4.4.3 Belize 165
4.4.4 Bolivia 165
4.4.5 Brazil 166
4.4.6 Chile 167
4.4.7 Colombia 168
4.4.8 Costa Rica 169
4.4.9 Ecuador 170
4.4.10 El Salvador 171
4.4.11 Guatemala 172
4.4.12 Guyana 172
4.4.13 Honduras 173
4.4.14 Mexico 174
4.4.15 Nicaragua 175
4.4.16 Panama 175
4.4.17 Paraguay 176
4.4.18 Peru 177
4.4.19 Uruguay 178
4.4.20 Venezuela 179
4.5 North America & the Caribbean: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail 179
4.5.1 Executive Summary 179
4.5.2 Barbados 182
4.5.3 Canada 183
4.5.4 Jamaica 183
4.5.5 St. Kitts and Nevis 184
4.5.6 the United States 184
4.5.7 Trinidad and Tobago 185
4.6 Oceana: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports in 2009 185
4.6.1 Executive Summary 185
4.6.2 Australia 187
4.6.3 New Caledonia 188
4.6.4 New Zealand 188
4.7 the Middle East: Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings Imports 189
4.7.1 Executive Summary 189
4.7.2 Armenia 192
4.7.3 Azerbaijan 193
4.7.4 Bahrain 193
4.7.5 Iran 194
4.7.6 Israel 194
4.7.7 Jordan 195
4.7.8 Kyrgyzstan 195
4.7.9 Oman 196
4.7.10 Pakistan 197
4.7.11 Qatar 198
4.7.12 Saudi Arabia 199
4.7.13 Syrian Arab Republic 200
4.7.14 Yemen 201
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 202
5.1 Disclaimers & Safe Harbor 202
5.2 ICON Group Ltd. User Agreement Provisions 203
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
